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Abstract
We present p53-MDM2-Glucose model to study spatio-temporal properties of the system induced by
glucose. The variation in glucose concentration level triggers the system at different states, namely,
oscillation death (stabilized), sustain and damped oscillations which correspond to various cellular states.
The transition of these states induced by glucose is phase transition like behaviour. We also found
that the intrinsic noise in stochastic system helps the system to stabilize more effectively. Further, the
amplitude of p53 dynamics with the variation of glucose concentration level follows power law behaviour,
As(k) ∼ kγ , where, γ is a constant.
Keywords: Glucose, p53, DNA damage, Oscillating states.
Introduction
Oscillations are inherent and inbuilt in living systems due to various fundamental molecular processes
and coordinate basic biological functions and their mechanisms [1] to self-organize the complicated life
processes [2]. The origin of these oscillations could be due to various control or feedback mechanisms and
set of non-linearities which describe complicated non-linear activities in the system [3]. p53 is one of most
important proteins in cellular system which contribute to the maintenance of the genomic integrity [4],
involves in various cellular activities, such as, cell cycle arrest, DNA repair, apoptosis and other cellular
functions [5–7], and exhibits oscillatory behaviour by interacting MDM2 via feedback mechanism [7].
Regulating p53, variety of cellular stresses, for example, global DNA damage that cause abnormal or
cancerous cells and repairing of stress-induced DNA damage, can be controlled [5,8]. Even though, p53 is
functionally inhibited in normal cells [6,9], the MDM2, which is a negative regulator of p53, can activate
p53 to induce stress in the cell [7, 10, 11].
The oscillatory behaviour exhibited by p53 due to negative feedback mechanism with MDM2 can be
regulated and induce stress by other molecular activities, such as, Ca2+, NO [12], MTBP [13] etc. and
excess stress may lead to apoptosis [11, 13, 14]. However, if the stress induced by various stress inducers
(NO, reactive oxygen synthase (ROS), ARF etc) is weak, on removing stress p53 activation may come
back to its normal functioning [15] which can be done by MDM2 by enhancing the ubiquitination of
p53, as a result of which p53 level degrades [14, 16].
However, there are many open issues regarding the role of glucose in cellular activities, for example,
switching of normal to stress states via glucose level in the cell, the way how excess stress caused by
glucose lead the cell to apoptosis, the possibilities to estimate the critical concentration of glucose that
cause the state transitions, the way how glucose effects p53 dynamics etc. We, in this work, study
the impact of glucose on ROS activation which cause DNA damage in p53-MDM2-Glucose network to
understand different states in the system and their transitions. The work is organized as follows. We
describe p53-MDM2-Glucose model and its molecular interaction with numerical techniques in section 2.
The numerical results are presented with discussions in section 3 and some conclusions are drawn based
on the results we obtained in section 4.
2Mathematical model of p53−MDM2 −Glucose network
The model we consider is the extension of p53 −MDM2 network [17] induced by two new and impor-
tant molecules namely stress inducer glucose and ROS, which damages DNA (Fig. 1). In the model,
p53 acts as a transcription factor and helps in the transcription of MDM2 mRNA via MDM2 gene.
MDM2 mRNA then synthesizes MDM2 protein through the translation process. p53 interacts with
MDM2 by enhancing its degradation through its E3 ubiquitin ligase activity [17] and maintains low con-
centration level at normal condition [10]. We then consider glucose metabolism inside cell which leads
to production of ROS [18] and high ROS concentration triggers the DNA damage [19,20] inducing stress
to the system [21, 22]. The DNA damage activates ARF and this activated ARF interacts with MDM2
forming ARF MDM2 complex [23, 24]. This activity of ARF blocks the MDM2 E3 ubiquitin ligase
activity which promotes MDM2 degradation [24]. Our model (Fig. 1) consists of nine molecular species
listed in Table 1 which undergo the reaction channels listed in Table 2.
Table 1 List of molecular species
S.No Molecular Species Description Notation
1. p53 Unbound p53 protein x1
2. MDM2 Unbound MDM2 protein x2
3. p53 MDM2 p53/MDM2 complex x3
4. MDM2 mRNA MDM2 messenger RNA x4
5. Glucose Unbound Glucose x5
6. ROS Unbound ROS x6
7. Dam DNA Damage DNA x7
8. ARF ARF protein x8
9. ARF MDM2 ARF/MDM2 complex x9
Cellular processes are basically noise induced stochastic processes [25] and this noise could be intrinsic
due to random molecular interaction in the system [26] as well as extrinsic due to fluctuations of physical
variables surrounding the system [27]. The intrinsic molecular interactions in our model system undergo
seventeen reaction channels (Table 2) and can be well explained in stochastic manner [26,28,29] as follows.
Consider a configurational state of our model system at any instant of time t is defined by a state
vector, ~X(t) = [X1(t), X2(t), . . . , XN (t)]
T , where, {Xi} is the set of variables corresponding to populations
of the molecular species (Table 1), N = 9, and T is the transpose of the vector. The time evolution of
the configurational probability P ( ~X; t) to have a transition from one configurational state ~X to another
state ~X(t)′ during the time interval [t, t+ dt] is given by the following Master equation,
∂P ( ~X(t), t)
∂t
=
∑
{ ~X}
P ( ~X(t), t)Γ ~X→ ~X′ −
∑
{ ~X′}
P ( ~X ′, t)Γ ~X′→ ~X (1)
where, {Γ} is the set of transition rates from one state to another. Since solving equation (1) is very
difficult for our system, we follow Gillespie [28] to simplify it to Chemical Langevin equations (CLE) as
follows. The number of reactions fired during the time interval [t, t+∆t] is a variable B(a) which depends
on propensity functions (a) of the reactions, and one can impose two important realistic approximations
in the large population limit to arrive at CLE. First in the limit, ∆t → 0, the values of a will remain
constant during [t, t + ∆t], which allows B to be replaced by statistically independent Poisson random
variable. The second approximation is ∆t → ∞ which allows to approximate Poisson random variable
by a normal variable, G with the same mean and variance. Now linearising G, we reach the following
3Table 2 List of biochemical reaction, Kinetic Law and their rate constant
S.No Reaction
channel
Description Kinetic
Law
Values of rate
constant
References
1 x4
k1−→ x4 + x2 MDM2 translation k1x3 4.95×10−4sec−1 [9, 13, 17].
2 x1
k2−→ x1 + x4 Synthesis of
MDM2 mRNA
k2x1 1.0× 10−4sec−1 [9, 13, 17].
3 x4
k3−→ φ Degradation of
MDM2 mRNA
k3x3 1.0× 10−4sec−1 [9, 13, 17].
4 x2
k4−→ φ Degradation of
MDM2
k4x2 4.33 ×
10−4sec−1
[9, 13, 17].
5 φ
k5−→ x1 Synthesis of p53 k5 0.78molsec−1 [9, 13, 17].
6 x3
k6−→ x2 Decay of p53 k6x3 8.25×10−4sec−1 [9, 13, 17].
7 x1 + x2
k7−→ x3 Synthesis of
p53 MDM2 com-
plex
k7x1x2 11.55 ×
10−4mol−1sec−1
[9, 13, 17].
8 x3
k8−→ x1 + x2 Dissociation of
p53 MDM2 com-
plex
k8x3 11.55 ×
10−6sec−1
[9, 13, 17].
9 φ
k9−→ x5 Creation of Glucose k9 k [mol−1sec−1] Assuming the con-
centration level of
glucose vary within
the cell.
10 x5
k10−→ x6 Synthesis of ROS k10x5 2 ×
10−3mol−1sec−1
Assuming ros pro-
duction due to the
glucose molecule.
11 x6
k11−→ x7 DNA damage k11x6 5× 10−4sec−1 [19, 32, 33].
12 x7
k12−→ φ DNA repair k12x7 2× 10−5sec−1 [9, 17].
13 x7
k13−→ x8 ARF activation k13x7 3.3× 10−5sec−1 [9, 17].
14 x2 +X8
k14−→ x9 Synthesis of
ARF/MDM2
complex
k14x2x8 1 ×
10−2mol−1sec−1
[9, 17].
15 x9
k15−→ x8 ARF dependent
MDM2 degradation
k15x9 1× 10−3sec−1 [9, 17].
16 x8
k16−→ φ Degradation of
ARF
k16x8 1× 10−3sec−1 [9, 17].
17 x5
k17−→ φ Degradation of
Glucose
k17x5 1× 10−4sec−1 Due to half life of
the molecule.
4CLE for our model,
dx1
dt
= k5 − k7x1x2 + k8x3 + 1√
V
[√
k5ξ1 −
√
k7x1x2ξ2 +
√
k8x4ξ3
]
(2)
dx2
dt
= k1x4 − k4x2 + k6x3 − k7x1x2 + k8x3 − k14x2x8
+
1√
V
[√
k1x4ξ4 −
√
k4x2ξ5 +
√
k6x4ξ6 −
√
k7x1x2ξ7
+
√
k8x3ξ8 −
√
k14x2x8ξ9
]
(3)
dx3
dt
= −k6x3 + k7x1x2 − k8x3
+
1√
V
[
−
√
k6x3ξ10 +
√
k7x1x2ξ11 −
√
k8x3ξ12
]
(4)
dx4
dt
= k2x1 − k3x4 + 1√
V
[√
k2x1ξ13 −
√
k3x4ξ14
]
(5)
dx5
dt
= k9 − k10x5 − k17x5 + 1√
V
[√
k9ξ15 −
√
k10x5ξ16 −
√
k17x5ξ17
]
(6)
dx6
dt
= k10x5 − k11x6 + 1√
V
[√
k10x5ξ18 −
√
k11x6ξ19
]
(7)
dx7
dt
= k11x6 − k12x7 + 1√
V
[√
k11x6ξ20 −
√
k12x7ξ21
]
(8)
dx8
dt
= k13x7 − k14x2x8 + k15x9 − k16x8 + 1√
V
[√
k13x7ξ22
−
√
k14x2x8ξ23 +
√
k15x9ξ24 +
√
k16x8ξ25
]
(9)
dx9
dt
= k14x2x8 − k15x9 + 1√
V
[√
k14x2x8ξ26 −
√
k15x9ξ27
]
(10)
where, {ξi} are random parameters which is given by, ξi = limdt→0Ni(0, 1)/
√
dt and satisfy ξi(t)ξj(t
′) =
δijδ(t− t′). When V →∞ or {ξ} → 0 the set of CLEs recover deterministic equations.
The dynamical behaviour of the system can be well studied by simulating the set of CLEs given
by equations (2)-(10) or corresponding deterministic differential equations by using standard 4th or-
der Runge-Kutta method [30] for numerical integration of the set of stochastic or ordinary differential
equations.
We use the stochastic simulation algorithm due to Gillespie [26] to calculate the time evolution of
state vector of the system by simulating the reaction sets given in Table 2 with the parameter values. The
algorithm is based on proposed joint probability density function P (τ, µ) = T (τ)R(µ) to allow a transition
to occur with time increment τ (= [0,∞]) by finding the probability densities, T (τ) at which a particular
reaction is fired and R(µ) which identifies the particular reaction µ = [1, 2, ..,M ] fired at that time.
From this hypothesis, τ and µ can be estimated computationally from the relations τ = −ln[T (τ)]/ao
and ωµ = ωoR(µ) by defining two random numbers r1 and r2 for T (τ) and R(µ) respectively and here
ao =
∑M
i=1 ai.
5Figure 1. The schematic diagram of p53-MDM2-Glucose interaction network which involves various
feedback loops induced by ARF protein and regulated indirectly by Glucose.
6Figure 2. Plots of a comparative behaviour of p53 and MDM2 as a function of time in hours (for 0 to
200 hours) due to the effect of rate constant of Glucose creation, for different values of k9=k=0.00005
,0.0005, 0.001, 0.005, 0.05 respectively, (i) Deterministic case (the first upper two row panels), (2)
Chemical Langevin equation (CLE) (the third and fourth row panels) and (3) Stochastic simulation
algorithm (SSA) (the fifth and sixth row panels). For CLE we have taken five values of system sizes i.e.
V=1, 50, 100, 500, 1000; and for SSA we have taken V=1, 25, 50, 75 and 100.
7Results and discussion
The dynamical behaviours of p53 and various states of the system induced by glucose concentration
levels in it are studied using three different computational techniques, namely, deterministic by solving
equations (2)-(10) where {ξ} → 0, CLE by solving equations (2)-(10) and stochastic simulation algorithm
by simulating the set of reactions listed in Table 2. The parameter values needed for the simulation are
also given in Table 2.
Transition of oscillating states: biological rules
The glucose concentration level (proportional to the rate k which is the rate of creation of glucose given
in reaction number 9 in Table 2) in the system, due to both synthesized by cellular processes and diffused
in from extracellular medium, drives the system to different oscillating states (Fig. 2). The p53 dynamics
maintains stabilized state with minimum p53 level at low values of k (k〈0.00007) and this state is not
much influenced by intrinsic noise in the system except some random fluctuation about the stabilized
state (Fig. 2 last four panels of first column). The two dimensional plots of p53 and p53 MDM2 in this
situation shows fixed point oscillation (oscillation with amplitude zero) (Fig. 4). This stabilized state of
p53 reflects the normal condition in cellular systems where p53 is maintained minimum level [13, 31].
The moderate concentration level of glucose in the system (0.0005〈k〈0.001) drives the p53 behaviour
to sustain oscillation state with increasing amplitudes as k increases (Fig. 2 second and third columns).
In this condition, two dimensional plots of p53 and p53 MDM2 show broaden limit cycle (Fig. 4).
The random fluctuation in p53 dynamics is minimized in deterministic system and start showing up
significantly in CLE and SSA where the fluctuations increases as noise strength increases (as V decreases).
The continuous and periodic changes in the p53 concentration level show the active participation of p53
in the molecular interaction described in Table 2 which involve creation and degradation of p53 and other
molecular species in the system. This sustain oscillation state, therefore, may correspond to activated or
stress state in cellular system induced by glucose.
The further increase in the glucose concentration level in the system (0.005〈k〈0.008) drives p53 dy-
namics from sustain to damped oscillation state and then to stabilized state (Fig. 2 fourth column). In
this situation, two dimensional plots of p53 and p53 MDM2 show spiral cycle towards fixed point (Fig.
4). Even though this is a clear damped state in deterministic system and CLE (noise strength is small), in
SSA (noise strength is comparatively large) the state is still sustain oscilation state with large amplitude.
This indicates that noise can also be taken as a parameter which can induce stress to the system.
However, if the glucose concentration level is high enough then the p53 dynamics goes to the stabilized
state again with high population (Fig. 2 last column). Similary, the comparative behaviour of Glucose,
ROS, Damaged DNA and ARF is shown in fig. 3, as a function of time in hours (for 0 to 200 hours)
due to the effect of rate constant of Glucose creation, for different values of k9=k=0.00005 ,0.0005,
0.001, 0.005, 0.05 respectively, (i) Deterministic case (the first upper row panels), (2) Chemical Langevin
equation (CLE) (the second, third, fourth and fifth row panels) and (3) Stochastic simulation algorithm
(SSA) (the sixth, seventh, eighth and nineth row panels). For CLE we have taken five values of system
sizes i.e. V=1, 50, 100, 500, 1000; and for SSA we have taken V=1, 25, 50, 75 and 100. (for different
colours code see figure 2). The result suggests that as the rate constant of glucose (which corresponds to
glucose concentration in the system) increaeses the stress within the systems first increases then finally
acheived an steady state at high value of rate constant.
In this condition, two dimensional plots of p53 and p53 MDM2 show fixed point oscillation again
(Fig. 4). In stochastic system, there is still oscillating behaviour at large strength of noise (V = 1) which
reveals that still noise tries to resist the system to go to stabilized state (Fig. 2 last column fifth panel).
This second stabilized state may correspond to apoptotic state because increasing glucose level the p53
dynamics will remain stabilized forever.
The time of activation Ts for p53 temporal dynamics, which can be defined as the time below which the
8Figure 3. Similar plot as shown in figure 2, of comparative behaviour of Glucose, ROS,
DamagedDNA and ARF as a function of time in hours (for 0 to 200 hours) due to the effect of rate
constant of Glucose creation, for different values of k9=k=0.00005 ,0.0005, 0.001, 0.005, 0.05
respectively, (i) Deterministic case (the first upper row panels), (2) Chemical Langevin equation (CLE)
(the second, third, fourth and fifth row panels) and (3) Stochastic simulation algorithm (SSA) (the
sixth, seventh, eighth and nineth row panels). For CLE we have taken five values of system sizes i.e.
V=1, 50, 100, 500, 1000; and for SSA we have taken V=1, 25, 50, 75 and 100. (for different colours code
see figure 2).
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Figure 4. Two dimensional plots of p53 for different values of k9 in deterministic, CLE (V=100) and
SSA (V=50).
dynamics show damped oscillation and above which it shows oscillation death or fixed point oscillation,
is calculated for different k values (Fig. 6) for deterministic, CLE and SSA. This phase diagram shows
various regimes of oscillation states and their switching boundaries. The error bars in each curve are due
to average over 30 ensembles. Further, we calculated amplitudes of the p53 dynamics (As) as a function
of k (Fig. 6 right column) which obeys power law behaviour with k in large k regime i.e. As(k) ∼ kγ .
All the curves of different V are found to be within the error bars showing the similar behaviour of the
system as a function of V.
Noise to stabilize the system
Noise has constructive role in regulating the system by trying to keep the system at normal condition
(stabilized condition), on removing the noise (as V increases) the system goes to activated or stress state
(Fig. 5). Further, noise also tries to save the stress state from going to apoptotic state (Fig. 2 fifth
panels of fourth and fifth columns). It is also evident from the curves in Fig. 6 that as V decreases the
curves shifts on the right hand side showing (i) helping the system to maintain in normal state by keeping
away from stress, indicated by larger area occupied towards oscillation death regime as V decreases (left
hand side of sustain oscillation in Fig. 6 left column) (ii) allowing the system to save from apoptosis by
slowing down to reach stabilized state (larger area occupied in oscillation death regime in right hand side
of sustain oscillation in Fig. 6 left column).
Stability solution
The stabilized solution of p53 and MDM2 can be obtained from the stationary conditions of the set of
equations (2)-(10) by putting d
dt
x = 0 and ξi → 0, ∀i. Solving for x∗1 from the nine stationary equations
we obtain the following equation,
x∗1 ∼ A
√
x∗5
(
1 +
B
x∗5
)
(11)
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Figure 5. Two dimensional plots of p53 for different values of V for fixed value of k: (i) CLE for
V = 1, 50, 100, 500, 1000 and (ii) SSA for the same values of V .
where, A =
√
k3k5k10k13k14
k2k7k12k16
(
1 + k8
k6
)
and B = k4k12k16
2k10k13k14
. The equation (11) shows that for large values
of glucose concentration x∗5 (stabilized condition for large glucose concentration), B/x
∗
5 → 0 which gives
x∗1 ∝
√
x∗5. For small values of glucose concentration, 1 + B/x
∗
5 ∼ B/x∗5, and we found that x∗1 ∝ 1√x∗
5
maintaining low p53 concentration level.
Similarly, the stabilized solution for MDM2 (x∗2) is given by,
x∗2 ∼ C
√
x∗5
B + x∗5
(12)
where, C =
√
k2k5k12k16
k3k7k10k13k14
(
1 + k8
k6
)
. At large glucose concentration level, 1 + B/x∗5 → 1 and equation
(12) gives, x∗2 ∝ 1√x∗
5
. Further, for low glucose concentration level 1 + x∗5/B → 1 such that x∗2 ∝ x∗5
showing Mdm2 level is at large as compared to higher glucose concentration level.
Conclusion
We investigated transition of various oscillatory states in p53-MDM2-Glucose model induced by glucose
[20]. Our simulation results in three approaches namely deterministic, CLE and SSA show three distinct
states, namely, oscillation death, damped and sustained oscillatiory states, and a clear transition among
these states induced by glucose concentration level. This transition could be the signature of transition
of p53 and MDM2 states from normal to stress, stress to apoptotic state induced by glucose.
Intrinsic noise associated with the system dynamics helps the system to maintain its stabilized state
and further helps to protect from apoptosis. However, there are other several points to be studied further
on the roles of noise, finding critical strength of noise below which the role of noise is constructive,
role of external noise in maintaining orderness in non-equilibrium and non-linear physical, chemical and
biological systems.
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